Literature DB >> 20128029

Metabolic investigations in patients with hepatitis B and C.

Abdul Aziz Mastoi1, Bikha Ram Devrajani, Syed Zulfiquar Ali Shah, Qasim Rohopoto, Sikander Ali Memon, Marya Baloch, Ghulam Ali Qureshi, Waqas Sami.   

Abstract

AIM: To investigate the similarities and dissimilarities in patients with hepatitis B and hepatitis C, clinically and metabolically.
METHODS: Fifty patients with hepatitis B virus and hepatitis C virus infection were included in this study, along with fifty healthy controls for comparison purposes. Intravenous blood (10 mL) samples from patients and healthy subjects were collected and made to clot before serum was separated and immediately levels of the enzymes, alkaline phosphatase (ALK), creatinine phosphokinase (CPK), lactate dehydrogenase (LDH), serum glutamate oxaloacetate transaminase (s-GOT) and serum glutamate pyruvate transaminase (s-GPT) were determined by a kit method. For total content of each metal the serum samples were analyzed using atomic absorption spectrophotometry. Levels of cholesterol, triglycerides, urea, creatinine and uric acid were determined using a kit method on Microlab 300.
RESULTS: Serum magnesium and copper levels remained unchanged, whereas the concentration of zinc decreased and iron increased significantly in both groups of patients. Total antioxidant activity was significantly decreased in both hepatitis B and C. Among the enzymes analyzed, ALK, s-GPT, LDH and s-GOT were all significantly increased in both patients with hepatitis B and C whereas CPK was significantly decreased in patients with hepatitis B and remained unchanged in patients with hepatitis C.
CONCLUSION: The information accumulated by this study will help provide a better understanding of involved metabolic processes in order to design appropriate therapeutic approaches for treating these patients, so they can recover and lead normal lives.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20128029      PMCID: PMC2816273          DOI: 10.3748/wjg.v16.i5.603

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center.

Authors:  O Trejo; M Ramos-Casals; M García-Carrasco; J Yagüe; S Jiménez; G de la Red; R Cervera; J Font; M Ingelmo
Journal:  Medicine (Baltimore)       Date:  2001-07       Impact factor: 1.889

Review 2.  Evaluation of abnormal liver function tests.

Authors:  J K Limdi; G M Hyde
Journal:  Postgrad Med J       Date:  2003-06       Impact factor: 2.401

3.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

4.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

Authors:  G Marchesini; M Brizi; G Bianchi; S Tomassetti; E Bugianesi; M Lenzi; A J McCullough; S Natale; G Forlani; N Melchionda
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

5.  Insulin resistance-associated hepatic iron overload.

Authors:  M H Mendler; B Turlin; R Moirand; A M Jouanolle; T Sapey; D Guyader; J Y Le Gall; P Brissot; V David; Y Deugnier
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

6.  Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.

Authors:  K Jurczyk; M Wawrzynowicz-Syczewska; A Boroń-Kaczmarska; Z Sych
Journal:  Med Sci Monit       Date:  2001 Sep-Oct

7.  Prevalence and clinical significance of hepatitis C virus infection in Thai patients with thalassemia.

Authors:  Wanchai Wanachiwanawin; Pairoj Luengrojanakul; Pornpan Sirangkapracha; Wattana Leowattana; Suthat Fucharoen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

8.  Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis.

Authors:  A L Williams; J H Hoofnagle
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

9.  Chronic hepatitis C infection in a patient with bone marrow hypoplasia.

Authors:  S Bethlen; K Chandrikakumari; L de Leval; J-B Giot; D Mukeba; P Leonard; F Frippiat; C Meuris; J Delwaide; M Moutschen
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

10.  Selenium, glutathione and glutathione peroxidases in blood of patients with chronic liver diseases.

Authors:  Jolanta Czuczejko; Bronisław A Zachara; Ewa Staubach-Topczewska; Waldemar Halota; Józef Kedziora
Journal:  Acta Biochim Pol       Date:  2003       Impact factor: 2.149

View more
  7 in total

1.  Knowledge levels and attitudes of health care professionals toward patients with hepatitis C infection.

Authors:  Farahnaz Joukar; Fariborz Mansour-Ghanaei; Fatemeh Soati; Panah Meskinkhoda
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

2.  A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI).

Authors:  Waqar Ahmad; Bushra Ijaz; Fouzia T Javed; Sana Gull; Humaira Kausar; Muhammad T Sarwar; Sultan Asad; Imran Shahid; Aleena Sumrin; Saba Khaliq; Shah Jahan; Asim Pervaiz; Sajida Hassan
Journal:  BMC Gastroenterol       Date:  2011-04-21       Impact factor: 3.067

3.  Association of HCV with diabetes mellitus: an Egyptian case-control study.

Authors:  Eman I Elhawary; Gamal F Mahmoud; Mai A El-Daly; Fatma A Mekky; Gamal G Esmat; Mohamed Abdel-Hamid
Journal:  Virol J       Date:  2011-07-26       Impact factor: 4.099

Review 4.  The sterile inflammation in the exacerbation of HBV-associated liver injury.

Authors:  Qiao Yang; Yu Shi; Ying Yang; Guohua Lou; Zhi Chen
Journal:  Mediators Inflamm       Date:  2015-03-29       Impact factor: 4.711

5.  Separation of hepatic iron and fat by dual-source dual-energy computed tomography based on material decomposition: an animal study.

Authors:  Jing Ma; Zhi-Qiang Song; Fu-Hua Yan
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

6.  Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients.

Authors:  Sadia Qamar Arain; Farah Naz Talpur; Naseem Aslam Channa; Muhammad Shahbaz Ali; Hassan Imran Afridi
Journal:  Lipids Health Dis       Date:  2017-03-01       Impact factor: 3.876

7.  A comparative study of serum lipid contents in pre and post IFN-alpha treated acute hepatitis C patients.

Authors:  Sadia Qamar Arain; Farah Naz Talpur; Naseem Aslam Channa
Journal:  Lipids Health Dis       Date:  2015-09-24       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.